Rheumatoid Arthritis Treatment - Small Molecules, Biologics, Therapy: Existing Disease-modifying Antirheumatic Drugs and Corticosteroids

Session Type: ACR Abstract Submissions
Tuesday, November 8, 2011: 2:30 PM-4:00 PM
W375a (McCormick Place West)
Moderators: Daniel E. Furst, MD, UCLA Medical School and Paul Emery, FRCP, MA, MD, Chapel Allerton Hospital
2:30 PM
Immediate and Delayed Impact of Oral Glucocorticoid Therapy On Risk of Serious Infection In Patients with Rheumatoid Arthritis: A Nested Case-Control Analysis Using a Weighted Cumulative Dose Model
William G. Dixon1, Michal Abrahamowicz2, Marie-Eve Beauchamp2, David W. Ray3, Sasha Bernatsky4, Samy Suissa5 and Marie-Pierre Sylvestre6, 1Arthritis Research UK Epidemiology Unit, The University of Manchester, Manchester, United Kingdom, 2McGill University, Montreal, QC, 3The University of Manchester, Manchester, United Kingdom, 4McGill UHC/RVH, Montreal, QC, 5Royal Victoria Hosp, McGill Un, Montreal, 6University of Montreal, Montreal, QC
2:45 PM
Successful Tapering of Glucocorticoids (GC) in Rheumatoid Arthritis Patients-Results From the Consortium of Rheumatology Researchers of North America Registry
Thasia G. Woodworth, Leading Edge Clinical Research, Stuart, FL, Elizabeth Thomas, Axio Research, LLC, Seattle, WA, Jeffrey D. Greenberg, New York University School of Medicine, New York, NY and Daniel E. Furst, UCLA, Los Angeles, CA
3:00 PM
Preliminary Results of a Multicentre Randomised Controlled Trial of Etanercept and Methotrexate to Induce Remission in Patients with Newly Diagnosed Inflammatory Arthritis
Edith Villeneuve, Leeds Institute of Molecular Medicine, Centre Hospitalier de l'Université de Montréal, Montréal, QC, Jackie L. Nam, NIHR Leeds Musculoskeletal Biomedical Research Unit , LIMM, University of Leeds., Leeds, United Kingdom, Elizabeth Hensor, NIHR-Leeds Musculoskeletal Biomedical Research Unit and Leeds Institute of Molecular Medicine, University of Leeds, Leeds, United Kingdom, Richard J. Wakefield, Leeds Institute of Molecular Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals, Leeds, United Kingdom, Philip G. Conaghan, NIHR-Leeds Biomedical Research Unit and Leeds Institute of Molecular Medicine, University of Leeds, Leeds, United Kingdom, Mike J. Green, York Teaching Hospital NHS Foundation Trust, Harrogate, United Kingdom, Andrew K. Gough, Harrogate District Hospital, Harrogate, United Kingdom, Mark Quinn, The York Hospital, York Teaching Hospital NHS Foundation Trust, York, United Kingdom, Richard J. Reece, University of Birmingham, Birmingham, United Kingdom, Sally R. Cox, SA Pathology / Flinders Medical Centre, Adelaide, Australia and Paul Emery, Chapel Allerton Hospital, Leeds, United Kingdom
3:15 PM
Subsequent Therapy of Patients with Biologic Response Modifiers or Disease-Modifying Antirheumatic Drugs After Coccidioidomycosis
Susan Knowles1, Sara Taroumian1, Jeffrey R. Lisse1, James Yanes1, Neil M. Ampel2, Eric P. Gall3, Rafael G. Grau1, Barbara Y. Bode2, Berchman A. Vaz4, John Galgiani5 and Susan E. Hoover1, 1University of Arizona, Tucson, AZ, 2Southern AZ VA Medical Center, Tucson, AZ, 3Arizona Arthritis Center, Tucson, AZ, 4Catalina Pointe Arthritis and Rheumatology, Tucson, AZ, 5Valley Fever Center for Excellence, Tucson, AZ
3:30 PM
Red Blood Cell Folate Polyglutamates Are An Important Determinant of RA Disease Activity In Patients On Methotrexate – Implications for Folic Acid Supplementation
Lisa K. Stamp1, Peter T. Chapman2, Murray Barclay1, Joel M. Kremer3 and Thierry Dervieux4, 1University of Otago, Christchurch, Christchurch, New Zealand, 2Christchurch Hospital, Christchurch, New Zealand, 3Albany Medical College and The Center for Rheumatology, Albany, NY, 43Exagen Diagnostics, Albuquerque, NM
3:45 PM
Discontinuation of Adalimumab without Functional and Structural Progress After Attaining Remission in Patients with Rheumatoid Arthritis
Yoshiya Tanaka1, Shintaro Hirata1, Shunsuke Fukuyo1, Masao Nawata2, Satoshi Kubo1, Kunihiro Yamaoka2 and Kazuyoshi Saito1, 1University of Occupational & Environmental Health, Japan, Kitakyushu, Japan, 2University of Occupational and Environmental Health, Japan, Kitakyushu, Japan
See more of: ACR Abstract Submissions

To see other sessions for this day, use the date buttons to the left.